Page 3 - ஹெப்ரான் நிறுவனம் ஆஃப் புற்றுநோயியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail By joining the global network of WIN, Gustave Roussy is expecting to increase its global impact and to help improve cancer outcomes across the world, said Prof. Jean-Charles Soria, General Director of Gustave Roussy. We are very proud to welcome Gustave Roussy back to WIN, said Dr. Richard L Schilsky, Chairman of WIN, and past ASCO Executive Vice President and Chief Medical Officer (2013-2021), Gustave Roussy is a leader among European cancer research centres with remarkable research, talented faculty and innovative leadership and will be a major asset for WIN. As a founding member of WIN, Gustave Roussy contributed to the vision and facilitated the launch of a global precision cancer medicine consortium that has come to fruition in WIN. We are delighted that they are returning to the Consortium at a pivotal time in its history.

Israel generalChevilly larueClaire pariselJean charles soriaGustave roussyRichardl schilskyJosep taberneroHebron institute of oncologyGeneral directorVice presidentChief medical officerPrecision oncologyScientific advisory boardHebron instituteMedicine healthClinical trials